Differences in Gene Expression Profiling and Biomarkers Between Histological Colorectal Carcinoma Subsets from the Serrated Pathway
Overview
Pathology
Authors
Affiliations
Aims: To discern the differences in expression profiling of two histological subtypes of colorectal carcinoma (CRC) arising from the serrated route (serrated adenocarcinoma (SAC) and CRC showing histological and molecular features of a high level of microsatellite instability (hmMSI-H) both sharing common features (female gender, right-sided location, mucinous histology, and altered CpG methylation), but dramatically differing in terms of prognosis, development of an immune response, and treatment options.
Methods And Results: Molecular signatures of SAC and hmMSI-H were obtained by the use of transcriptomic arrays; quantitative polymerase chain reaction (qPCR) and immunohistochemistry (IHC) were used to validate differentially expressed genes. An over-representation of innate immunity functions (granulomonocytic recruitment, chemokine production, Toll-like receptor signalling, and antigen processing and presentation) was obtained from this comparison, and intercellular cell adhesion molecule-1 (ICAM1) was more highly expressed in hmMSI-H, whereas two genes [those encoding calcitonin gene-related peptide-receptor component protein and C-X-C motif chemokine ligand 14 (CXCL14)] were more highly expressed in SAC. These array results were subsequently validated by qPCR, and by IHC for CXCL14 and ICAM1. Information retrieved from public databanks confirmed our findings.
Conclusions: Our findings highlight specific functions and genes that provide a better understanding of the role of the immune response in the serrated pathological route and may be of help in identifying actionable molecules.
CXCL14 in prostate cancer: complex interactions in the tumor microenvironment and future prospects.
Tang L, Chen X, Hou J, Wei X J Transl Med. 2025; 23(1):9.
PMID: 39755616 PMC: 11700453. DOI: 10.1186/s12967-024-06022-9.
Role of CALCR expression in liver cancer: Implications for the immunotherapy response.
Wang S, Wang W, Zeng J Mol Med Rep. 2024; 31(2).
PMID: 39611512 PMC: 11622006. DOI: 10.3892/mmr.2024.13406.
The role of microvesicles as biomarkers in the screening of colorectal neoplasm.
Eddama M, Gurung R, Fragkos K, Lorgelly P, Cohen R, Loizidou M Cancer Med. 2022; 11(15):2957-2968.
PMID: 35343093 PMC: 9359869. DOI: 10.1002/cam4.4664.
Turpin-Sevilla M, Perez-Sanz F, Garcia-Solano J, Sebastian-Leon P, Trujillo-Santos J, Carbonell P Cancers (Basel). 2021; 13(20).
PMID: 34680315 PMC: 8533997. DOI: 10.3390/cancers13205165.
Alburquerque-Gonzalez B, Lopez-Calderon F, Lopez-Abellan M, Esteban-Gil A, Garcia-Solano J, Conesa-Zamora P Int J Mol Sci. 2020; 21(6).
PMID: 32183342 PMC: 7139914. DOI: 10.3390/ijms21061991.